Table 4.
Characteristics of decliners and nondecliners at the EDIC study visit.
| Clinical parameters | Decliners; N = 22 | Nondecliners; N = 51 | P‐value* |
|---|---|---|---|
| EDIC year visit | 18 (8–26) | 15 (9–24) | 0.12 |
| Age (years) | 47 (25–62) | 51 (28–61) | 0.05 |
| Males % | 45 | 61 | 0.99 |
| Disease duration (months) | 261 (108–408) | 260 (132–408) | 0.66 |
| HbA1C (%) | 9.1 (5.5–12.7) | 8.1 (6–11) | 0.03 |
| SBP (mmHg) | 140 (104–173) | 134 (102–155) | 0.09 |
| DBP (mmHg) | 83 (56–102) | 81 (60–100) | 0.81 |
| Intensive treatment (%) | 10 (45%) | 19 (37%) | 0.6 |
| Standard treatment(%) | 12 (55%) | 32 (63%) | 0.6 |
|
eGFR (ml/min per 1.73 m2) Median and range |
85 (61–119) | 91 (61–120) | 0.47 |
|
AER (mg/24 hr) Median and range |
391 (4.7–357) | 10 (1–951) | <0.001 |
|
AOG/creat (ng/mg) Median and range |
26 (1–989) | 4.0 (0.4–228) | 0.003 |
*
P value as per Wilcoxon test.